Å
Åsa B. Gustafsson
Researcher at University of Montana
Publications - 104
Citations - 20495
Åsa B. Gustafsson is an academic researcher from University of Montana. The author has contributed to research in topics: Autophagy & Mitochondrion. The author has an hindex of 49, co-authored 92 publications receiving 16938 citations. Previous affiliations of Åsa B. Gustafsson include Scripps Research Institute & University of California, San Diego.
Papers
More filters
Journal ArticleDOI
Juvenile Exposure to Anthracyclines Impairs Cardiac Progenitor Cell Function and Vascularization Resulting in Greater Susceptibility to Stress-Induced Myocardial Injury in Adult Mice
Chengqun Huang,Xiaoxue Zhang,Jennifer Ramil,Shivaji Rikka,Lucy Kim,Youngil Lee,Natalie Gude,Patricia A. Thistlethwaite,Mark A. Sussman,Roberta A. Gottlieb,Åsa B. Gustafsson +10 more
TL;DR: The data suggest that anthracycline treatment impairs vascular development as well as progenitor cell function in the young heart, resulting in an adult heart that is more susceptible to stress.
Journal ArticleDOI
Bnip3 mediates mitochondrial dysfunction and cell death through Bax and Bak
TL;DR: It is suggested that Bnip3 mediates mitochondrial dysfunction through activation of Bax or Bak which is independent of mPTP opening.
Journal ArticleDOI
Bnip3-mediated mitochondrial autophagy is independent of the mitochondrial permeability transition pore
TL;DR: The results support a model where Bnip3 induces selective removal of the mitochondria in cardiac myocytes, and that BnIP3 triggers induction of autophagy independent of Ca2+, ROS generation, and mPTP opening.
Journal ArticleDOI
Recycle or die: The role of autophagy in cardioprotection
TL;DR: The literature is reviewed and the evidence that autophagy can have both beneficial and detrimental roles in the myocardium depending on the level of Autophagy is discussed, and potential mechanisms by which autophagic provides protection in cells are discussed.
Journal ArticleDOI
Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation.
TL;DR: It is shown that transduction of TAT-ARCL31F, a mutant of ARC in the caspase recruitment domain, did not reduce creatine kinase release and infarct size after I/R, and ARC can protect against cell death by interfering with activation of the mitochondrial death pathway through the interaction with Bax, preventing mitochondrial dysfunction and release of pro-apoptotic factors.